• Je něco špatně v tomto záznamu ?

The Gastroepiploic Vascularized Lymph Node Transfer in the Treatment of Male Genital Lymphedema: A Report of Three Cases

M. Morelli Coppola, W. Gawel, R. Elia, E. Uldry, M. Nicod Lalonde, M. Maruccia, PG. di Summa

. 2025 ; 45 (5) : e70072. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25015173

Male genital lymphedema (MGL) is a debilitating condition that may require surgical intervention. Lymphaticovenous anastomosis (LVA) can be ineffective in primary and advanced cases because of lymphatic disruption, whereas vascularized lymph node transfer (VLNT) can overcome this limitation by promoting neolymphangiogenesis but traditionally carries some risk of donor site complications. Gastroepiploic vascularized lymph node transfer (GEVLNT) has recently emerged as an effective treatment option for upper and lower limb lymphedema, with negligible complications. However, its role in genital lymphedema remains unexplored. This is the first short series reporting the use of GEVLNT in MGL. Three male patients (44, 61, and 52 years old) with GL underwent GEVLNT. The first patient had idiopathic disease, which relapsed after previous treatment with LVA; the other two had secondary lymphedema due to cancer treatment and hydrocele surgery, respectively. In all patients, the right gastroepiploic lymphosome was harvested laparoscopically, with flap sizes of 14 × 5 cm, 15 × 4 cm, and 12 × 4 cm, respectively. The recipient vessels were the deep inferior epigastric artery and vein in the first case, and the superficial external pudendal vessels in the other two. Post-operative courses were uneventful for all patients, with no complications reported. Follow-up periods were 36, 23, and 12 months, respectively. In all cases, GEVLNT resulted in significant clinical improvements and reductions in genital lymphedema severity (GLS) scores (7-1, 9-4, and 8-4). Our preliminary experience suggests that GEVLNT could be a viable and effective option for treating male genital lymphedema with minimal donor site morbidity and stable results over time. However, further research with larger patient cohorts, comparative studies, and long-term follow-up is needed to fully establish its efficacy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25015173
003      
CZ-PrNML
005      
20250731090811.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/micr.70072 $2 doi
035    __
$a (PubMed)40439457
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Morelli Coppola, Marco $u Operative Research Unit of Plastic, Reconstructive and Aesthetic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy $u Department of Plastic and Hand Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000289106586
245    14
$a The Gastroepiploic Vascularized Lymph Node Transfer in the Treatment of Male Genital Lymphedema: A Report of Three Cases / $c M. Morelli Coppola, W. Gawel, R. Elia, E. Uldry, M. Nicod Lalonde, M. Maruccia, PG. di Summa
520    9_
$a Male genital lymphedema (MGL) is a debilitating condition that may require surgical intervention. Lymphaticovenous anastomosis (LVA) can be ineffective in primary and advanced cases because of lymphatic disruption, whereas vascularized lymph node transfer (VLNT) can overcome this limitation by promoting neolymphangiogenesis but traditionally carries some risk of donor site complications. Gastroepiploic vascularized lymph node transfer (GEVLNT) has recently emerged as an effective treatment option for upper and lower limb lymphedema, with negligible complications. However, its role in genital lymphedema remains unexplored. This is the first short series reporting the use of GEVLNT in MGL. Three male patients (44, 61, and 52 years old) with GL underwent GEVLNT. The first patient had idiopathic disease, which relapsed after previous treatment with LVA; the other two had secondary lymphedema due to cancer treatment and hydrocele surgery, respectively. In all patients, the right gastroepiploic lymphosome was harvested laparoscopically, with flap sizes of 14 × 5 cm, 15 × 4 cm, and 12 × 4 cm, respectively. The recipient vessels were the deep inferior epigastric artery and vein in the first case, and the superficial external pudendal vessels in the other two. Post-operative courses were uneventful for all patients, with no complications reported. Follow-up periods were 36, 23, and 12 months, respectively. In all cases, GEVLNT resulted in significant clinical improvements and reductions in genital lymphedema severity (GLS) scores (7-1, 9-4, and 8-4). Our preliminary experience suggests that GEVLNT could be a viable and effective option for treating male genital lymphedema with minimal donor site morbidity and stable results over time. However, further research with larger patient cohorts, comparative studies, and long-term follow-up is needed to fully establish its efficacy.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a lymfedém $x chirurgie $x etiologie $7 D008209
650    _2
$a lidé středního věku $7 D008875
650    12
$a lymfatické uzliny $x transplantace $x krevní zásobení $7 D008198
650    _2
$a dospělí $7 D000328
650    12
$a arteria gastroepiploica $x transplantace $7 D024405
650    12
$a nemoci mužských pohlavních orgánů $x chirurgie $7 D005832
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gawel, Wladyslaw $u Centre for Plastic and Hand Surgery, University Hospital in Ostrava, Ostrava, Czech Republic
700    1_
$a Elia, Rossella $u Department of Plastic and Reconstructive Surgery, Policlinico di Bari, University of Bari Aldo Moro, Bari, Italy
700    1_
$a Uldry, Emilie $u Department of Visceral Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
700    1_
$a Nicod Lalonde, Marie $u Department of Nuclear Medicine and Molecular Imaging, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland
700    1_
$a Maruccia, Michele $u Department of Plastic and Reconstructive Surgery, Policlinico di Bari, University of Bari Aldo Moro, Bari, Italy $1 https://orcid.org/0000000221222732
700    1_
$a di Summa, Pietro Giovanni $u Department of Plastic and Hand Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland $1 https://orcid.org/0000000214314479
773    0_
$w MED00003349 $t Microsurgery $x 1098-2752 $g Roč. 45, č. 5 (2025), s. e70072
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40439457 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731090805 $b ABA008
999    __
$a ok $b bmc $g 2366182 $s 1252298
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 45 $c 5 $d e70072 $e - $i 1098-2752 $m Microsurgery $n Microsurgery $x MED00003349
LZP    __
$a Pubmed-20250708

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...